Pharmadox Healthcare Ltd., STADA Arzneimittel AG
PolandAll drugs from this manufacturer
-
The medicine is used in adults to treat high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML).
Dosage form: powder for preparation of injection suspension
Active substance Dosage azacitidine 100 mg ATC: L01BC07
-
The medicine is used to treat influenza in adults, adolescents, children, and infants. It may also be used to prevent influenza or as preventive treatment in exceptional circumstances, e.g., during a pandemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir phosphate 39.4 mg ATC: J05AH02
-
The medicine is used in adults, adolescents, children, and infants for the treatment of influenza and for the prevention of influenza (e.g., after contact with an infected person). It may also be used as prophylactic treatment in exceptional situations, such as a pandemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir phosphate 59.1 mg ATC: J05AH02
-
The medicine is used in adults, adolescents, children, and infants to treat influenza or to prevent its occurrence (e.g., after contact with an infected person). It may also be used as preventive treatment in exceptional situations, such as a pandemic.
Dosage form: capsules, hard
Active substance Dosage oseltamivir phosphate 98.5 mg ATC: J05AH02